Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:329-334
Published online before print October 25, 2007, doi: 10.1161/ATVBAHA.107.156273
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/2/329    most recent
ATVBAHA.107.156273v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berny, M. A.
Right arrow Articles by McCarty, O. J.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berny, M. A.
Right arrow Articles by McCarty, O. J.T.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:329.)
© 2008 American Heart Association, Inc.

Cell Biology/Signaling

Thrombin Mutant W215A/E217A Acts as a Platelet GPIb Antagonist

Michelle A. Berny; Tara C. White; Erik I. Tucker; Leslie A. Bush-Pelc; Enrico Di Cera; András Gruber; Owen J.T. McCarty

From the Departments of Biomedical Engineering (M.A.B., T.C.W., E.I.T., A.G., O.J.T.M.) and Cell and Developmental Biology (O.J.T.M.), Oregon Health and Science University, Portland; and Biochemistry and Molecular Biophysics (L.A.B.-P., E.D.C.), Washington University, St. Louis, Mo.

Correspondence to Owen J.T. McCarty, Department of Biomedical Engineering, Oregon Health & Science University, 3303 SW Bond Ave, Portland, OR 97239. E-mail mccartyo{at}ohsu.edu

Abstract

Objective— Thrombin containing the mutations Trp215Ala and Glu217Ala (WE) selectively activates protein C and has potent antithrombotic effects in primates. The aim of this study was to delineate the molecular mechanism of direct WE–platelet interactions under static and shear conditions.

Methods and Results— Purified platelets under static conditions bound and spread on immobilized wild-type but not WE thrombin. In PPACK-anticoagulated blood under shear flow conditions, platelets tethered and rolled on both wild-type and WE thrombin, and these interactions were abrogated by the presence of a glycoprotein Ib (GPIb)-blocking antibody. Platelet deposition on collagen was blocked in the presence of WE, but not wild-type thrombin or prothrombin. WE also abrogated platelet tethering and rolling on immobilized von Willebrand factor in whole blood under shear flow.

Conclusions— These observations demonstrate that the thrombin mutant WE, while not activating platelets, retains the ability to interact with platelets through GPIb, and inhibits GPIb-dependent binding to von Willebrand factor–collagen under shear.

The thrombin mutant WE selectively activates protein C and has potent antithrombotic effects in primates. We demonstrate that WE, while not activating platelets, retains the ability to interact with platelets through GPIb, and inhibits GPIb-dependent binding to vWF-collagen under shear.


Key Words: platelet • thrombin • von Willebrand factor • GPIb


Related Article:

New Direction for WE Thrombin
Michael C. Berndt and Robert K. Andrews
Arterioscler Thromb Vasc Biol 2008 28: 205-207. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. C. White-Adams, M. A. Berny, E. I. Tucker, J. M. Gertz, D. Gailani, R. T. Urbanus, P. G. de Groot, A. Gruber, and O. J.T. McCarty
Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2)
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1602 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. S. Petrera, A. R. Stafford, B. A. Leslie, C. A. Kretz, J. C. Fredenburgh, and J. I. Weitz
Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function
J. Biol. Chem., September 18, 2009; 284(38): 25620 - 25629.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Bah, C. J. Carrell, Z. Chen, P. S. Gandhi, and E. Di Cera
Stabilization of the E* Form Turns Thrombin into an Anticoagulant
J. Biol. Chem., July 24, 2009; 284(30): 20034 - 20040.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Auger and S. P. Watson
Dynamic Tyrosine Kinase-Regulated Signaling and Actin Polymerisation Mediate Aggregate Stability Under Shear
Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1499 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Berndt and R. K. Andrews
New Direction for WE Thrombin
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 205 - 207.
[Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.